Chronic Myeloid Leukemia Coverage from Every Angle

Melinda Tran, PharmD, BCOP, on Dasatinib for CML and Supportive Care

Posted: Friday, November 16, 2018

When a patient experiences a hematologic adverse effect such as anemia or neutropenia, how do you decide on a supportive maneuver?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.